メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
新庄 正宜
小児科学
ウェブサイト
https://k-ris.keio.ac.jp/html/100004830_ja.html
h-index
911
被引用数
17
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
1991 …
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(74)
類似のプロファイル
(6)
フィンガープリント
Masayoshi Shinjo(H)が活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Pharmacology, Toxicology and Pharmaceutical Science
Aciclovir
12%
Acute Appendicitis
12%
Antibiotic Agent
14%
Bacteremia
12%
Bacterial Meningitis
51%
Batrachotoxin
12%
Campylobacter Jejuni
12%
Carbapenem
22%
Case-Control Study
19%
Chickenpox
24%
Clindamycin
12%
Clinical Feature
12%
Cohort Study
12%
Congenital Syphilis
12%
Disease
33%
Escherichia coli
25%
Esophagus Atresia
12%
Haemophilus influenzae
18%
Haemophilus Influenzae Type B
12%
Haemophilus Influenzae Type B Vaccine
13%
Human Bocavirus
12%
Human Rhinovirus
12%
Inborn Error of Metabolism
12%
Infection
32%
Infectious Agent
12%
Influenza A
100%
Influenza A Virus (H1N1)
18%
Influenza A Virus (H3N2)
12%
Influenza B
87%
Influenza Vaccine
81%
Listeria monocytogenes
12%
Live Attenuated Influenza Vaccine
25%
Live Vaccine
25%
Lung Hypoplasia
12%
Neuromuscular Disease
12%
Oseltamivir
25%
Palivizumab
12%
Pandemic Influenza
12%
Penicillinase
12%
Pneumococcal Infection
12%
Pneumococcus Vaccine
16%
Respiratory Tract Disease
12%
Retrospective Study
14%
Sodium Channel
12%
Staphylococcus Aureus
12%
Streptococcus Pneumoniae
21%
Urinary Tract Infection
12%
Vaccination Policy
14%
Varicella Zoster Virus
12%
Veratridine
12%
Medicine and Dentistry
Acute Kidney Injury
12%
Antibiotics
12%
Bacterial Meningitis
12%
Catheter Infection
12%
Cell Compartment
12%
Chickenpox
13%
Chimeric Antigen Receptor T-Cell Immunotherapy
12%
Chlamydophila pneumoniae
12%
Cohort Analysis
12%
Congenital Syphilis
12%
Cost-Effectiveness Analysis
12%
COVID-19
38%
Design Controls
17%
Differential Diagnosis
12%
Disease
35%
Drug Dose Regimen
12%
Epstein-Barr Virus Infection
12%
Escherichia coli
12%
Heart Graft
12%
Influenza A
69%
Influenza B
60%
Influenza Vaccination
12%
Influenza Vaccine
64%
Kidney Graft
12%
Linezolid
12%
Listeria monocytogenes
12%
Live Vaccine
38%
Liver Graft
31%
Liver Transplantation
25%
Meticillin
10%
Neonate
12%
Nocturnal Enuresis
12%
Odds Ratio
22%
Outpatient
12%
Pediatrics
55%
Penicillinase
12%
Pneumococcal Infection
19%
Pneumococcus Vaccine
25%
Pneumocystis Jirovecii
12%
Rapid Diagnostic Test
19%
Respiratory Infectious Disease
12%
Rubella
20%
Sepsis
12%
Serotype
15%
Streptococcus Agalactiae
12%
T Cell
14%
T-Helper Cell
21%
Toddlers
12%
Vaccine Failure
12%
Vancomycin Resistant Enterococcus
12%
Keyphrases
20-valent Pneumococcal Conjugate Vaccine
12%
Aciclovir
12%
Actinobaculum
12%
Age Groups
16%
Bacterial Meningitis
23%
Batrachotoxin
12%
Carbapenem Use
12%
Catheter-related Bloodstream Infection (CRBSI)
12%
Clindamycin Resistance
12%
Co-circulation
15%
Confidence Interval
24%
COVID-19
27%
COVID-19 Pandemic
12%
Dermacoccus
12%
Fractional Excretion of Urea
12%
Haemophilus Influenzae Type b
12%
Haemophilus Influenzae Type b Vaccine
15%
Hospitalized children
12%
Human Rhinovirus
12%
Immunochromatography Test
12%
Immunocompetent child
12%
Inactivated Influenza Vaccine
35%
Influenza
20%
Influenza A
31%
Influenza B
23%
Influenza Hospitalization
16%
Japan
54%
Live Attenuated Vaccine
16%
Pediatric Bacterial Meningitis
25%
Pediatric Vaccination
12%
Pediatric Ward
25%
Post-COVID-19 Era
12%
Post-liver Transplant
14%
Postoperative Acute Kidney Injury
12%
Pre-exposure Prophylaxis (PrEP)
25%
Prospective Monitoring
12%
Rapid Antigen Test
12%
Respiratory Risk
12%
Round Pneumonia
12%
S. Argenteus
21%
S. Pneumoniae
15%
Streptococcus Agalactiae
25%
Streptococcus Pneumoniae
18%
Treatment Response
12%
Trivalent Inactivated Influenza Vaccine
12%
Updated Data
12%
Vaccine Booster
12%
Vaccine Effectiveness
30%
Vaccines for Children Program
16%
Veratridine
12%
